In this discussion, a US-based KOL speaks about the treatment algorithm in both ulcerative colitis and Crohn's disease. The KOL discusses the treatment options across the indications, focusing on the real-world problems faced by patients and physicians alike. The KOL also talks on the emerging treatment options that have recently been approved, and also on the novel pipeline therapies awaiting launch. 

This interview was conducted on 9 August 2024. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.